Non-convulsive seizure related to Cremophor EL™-free,polymeric micelle formulation of paclitaxel: A case report

Yoon Sun Shin, Kyung Jin Min, Seung Young Choi, Nak Woo Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Paclitaxel is a chemotherapeutic agent that is effective against ovarian, breast, lung, and other cancers. Although peripheral neurotoxicity is among the most common side effects of paclitaxel treatment, central neurotoxicity is rarely reported. When centrally mediated side effects are observed, they are attributed to Cremophor EL™ (CrEL), a surfactant-containing vehicle used for paclitaxel administration. In the present report, we discuss the case of a 72-yearold woman with ovarian carcinoma who experienced a non-convulsive seizure following administration of a CrELfree, polymeric micelle formulation of paclitaxel. One week after her fourth round of chemotherapy, she experienced a transient episode of aphasia for 45 minutes. Electroencephalography demonstrated epileptiform discharges. To our knowledge, this is the first reported case of seizure associated with a CrEL-free formulation of paclitaxel. Although rare, patients and clinicians should remain aware of the risk of non-convulsive seizure following infusion of this paclitaxel formulation.

Original languageEnglish
Pages (from-to)421-424
Number of pages4
JournalObstetrics and Gynecology Science
Volume61
Issue number3
DOIs
Publication statusPublished - 2018 May 1

Fingerprint

Micelles
Paclitaxel
Seizures
Aphasia
Surface-Active Agents
cremophor EL
Electroencephalography
Lung Neoplasms
Breast
Carcinoma
Drug Therapy

Keywords

  • Cremophor
  • Neurotoxicity
  • Paclitaxel
  • Seizures

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Non-convulsive seizure related to Cremophor EL™-free,polymeric micelle formulation of paclitaxel : A case report. / Shin, Yoon Sun; Min, Kyung Jin; Choi, Seung Young; Lee, Nak Woo.

In: Obstetrics and Gynecology Science, Vol. 61, No. 3, 01.05.2018, p. 421-424.

Research output: Contribution to journalArticle

@article{84ae5b03503a4266ba824df9f32421c9,
title = "Non-convulsive seizure related to Cremophor EL™-free,polymeric micelle formulation of paclitaxel: A case report",
abstract = "Paclitaxel is a chemotherapeutic agent that is effective against ovarian, breast, lung, and other cancers. Although peripheral neurotoxicity is among the most common side effects of paclitaxel treatment, central neurotoxicity is rarely reported. When centrally mediated side effects are observed, they are attributed to Cremophor EL™ (CrEL), a surfactant-containing vehicle used for paclitaxel administration. In the present report, we discuss the case of a 72-yearold woman with ovarian carcinoma who experienced a non-convulsive seizure following administration of a CrELfree, polymeric micelle formulation of paclitaxel. One week after her fourth round of chemotherapy, she experienced a transient episode of aphasia for 45 minutes. Electroencephalography demonstrated epileptiform discharges. To our knowledge, this is the first reported case of seizure associated with a CrEL-free formulation of paclitaxel. Although rare, patients and clinicians should remain aware of the risk of non-convulsive seizure following infusion of this paclitaxel formulation.",
keywords = "Cremophor, Neurotoxicity, Paclitaxel, Seizures",
author = "Shin, {Yoon Sun} and Min, {Kyung Jin} and Choi, {Seung Young} and Lee, {Nak Woo}",
year = "2018",
month = "5",
day = "1",
doi = "10.5468/ogs.2018.61.3.421",
language = "English",
volume = "61",
pages = "421--424",
journal = "Obstetrics and Gynecology Science",
issn = "2287-8572",
publisher = "Korean Society of Obstetrics and Gynecology",
number = "3",

}

TY - JOUR

T1 - Non-convulsive seizure related to Cremophor EL™-free,polymeric micelle formulation of paclitaxel

T2 - A case report

AU - Shin, Yoon Sun

AU - Min, Kyung Jin

AU - Choi, Seung Young

AU - Lee, Nak Woo

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Paclitaxel is a chemotherapeutic agent that is effective against ovarian, breast, lung, and other cancers. Although peripheral neurotoxicity is among the most common side effects of paclitaxel treatment, central neurotoxicity is rarely reported. When centrally mediated side effects are observed, they are attributed to Cremophor EL™ (CrEL), a surfactant-containing vehicle used for paclitaxel administration. In the present report, we discuss the case of a 72-yearold woman with ovarian carcinoma who experienced a non-convulsive seizure following administration of a CrELfree, polymeric micelle formulation of paclitaxel. One week after her fourth round of chemotherapy, she experienced a transient episode of aphasia for 45 minutes. Electroencephalography demonstrated epileptiform discharges. To our knowledge, this is the first reported case of seizure associated with a CrEL-free formulation of paclitaxel. Although rare, patients and clinicians should remain aware of the risk of non-convulsive seizure following infusion of this paclitaxel formulation.

AB - Paclitaxel is a chemotherapeutic agent that is effective against ovarian, breast, lung, and other cancers. Although peripheral neurotoxicity is among the most common side effects of paclitaxel treatment, central neurotoxicity is rarely reported. When centrally mediated side effects are observed, they are attributed to Cremophor EL™ (CrEL), a surfactant-containing vehicle used for paclitaxel administration. In the present report, we discuss the case of a 72-yearold woman with ovarian carcinoma who experienced a non-convulsive seizure following administration of a CrELfree, polymeric micelle formulation of paclitaxel. One week after her fourth round of chemotherapy, she experienced a transient episode of aphasia for 45 minutes. Electroencephalography demonstrated epileptiform discharges. To our knowledge, this is the first reported case of seizure associated with a CrEL-free formulation of paclitaxel. Although rare, patients and clinicians should remain aware of the risk of non-convulsive seizure following infusion of this paclitaxel formulation.

KW - Cremophor

KW - Neurotoxicity

KW - Paclitaxel

KW - Seizures

UR - http://www.scopus.com/inward/record.url?scp=85047081861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047081861&partnerID=8YFLogxK

U2 - 10.5468/ogs.2018.61.3.421

DO - 10.5468/ogs.2018.61.3.421

M3 - Article

AN - SCOPUS:85047081861

VL - 61

SP - 421

EP - 424

JO - Obstetrics and Gynecology Science

JF - Obstetrics and Gynecology Science

SN - 2287-8572

IS - 3

ER -